BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 16, 1993
View Archived Issues
BISPECIFIC MAB DESIGNATED ORPHAN DRUG FOR CANCER
Read More
HIGH RESPONSE RATE TO TAXOTERE IN BREAST CANCER
Read More
AFFYMAX CREATES NEW LARGE-SCALE DRUG SCREEN
Read More
GENE THERAPY COMMITTEE FORMED IN BRITAIN
Read More
INCYTE TALLIES $17.25 MILLION FROM IPO
Read More
MACROCHEM'S PRIVATE PLACEMENT DECLARED EFFECTIVE
Read More
MEDIMMUNE'S CMV TREATMENT EFFECTIVE
Read More
BRITISH HOPE TO EXPLOIT GENETIC INFORMATION
Read More
JOINT VENTURE TO DEVELOP GLUCANS AS ADJUVANTS
Read More
BIOTECH SHUT OUT OF SENATE HEARING
Read More